Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8938816 | 0.82 | TDP1 (0.35) | TDP1ATMALDH1A1HIF1AVCAM1 | |
| SCHEMBL28088340 | 0.78 | TDP1 (0.36) | TDP1ATMALDH1A1HIF1AVCAM1 | |
| SCHEMBL28545972 | 0.78 | ALDH1A1 (0.36) | TDP1ATMALDH1A1HIF1AVCAM1 | |
| SCHEMBL25356732 | 0.78 | GPR35 (0.36) | TDP1ATMALDH1A1HIF1AVCAM1 | |
| SCHEMBL18478 | 0.78 | TSHR (0.42) | TDP1ATMALDH1A1CYP3A4MEN1 | |
| SCHEMBL9789548 | 0.76 | ALDH1A1 (0.42) | TDP1ALDH1A1VCAM1CYP3A4 | |
| SCHEMBL3047388 | 0.76 | GPR35 (0.46) | TDP1ALDH1A1HIF1ACYP3A4 | |
| SCHEMBL7646276 | 0.76 | ABCC8 (0.36) | TDP1ALDH1A1 | |
| SCHEMBL2075135 | 0.73 | MAPT (0.36) | TDP1ATMALDH1A1HIF1AVCAM1 | |
| SCHEMBL10731966 | 0.73 | ALDH1A1 (0.39) | TDP1ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021087048-A1 | CROSS-LINKED POLYROTAXANES AND THEIR APPLICATION IN CEMENT | SAUDI ARABIAN OIL COMPANY (SA) | 2021-05-06 | — | — | WO | claimed |
| US-20210130676-A1 | CROSS-LINKED POLYROTAXANES AND THEIR APPLICATION IN CEMENT | SAUDI ARABIAN OIL COMPANY (SA) | 2021-05-06 | — | — | US | claimed |
| EP-1658503-B1 | CHEMILUMINESCENT COMPOUNDS | MOLECULAR LIGHT TECH RES LTD (GB) | 2009-11-18 | — | — | EP | claimed |
| US-20070166759-A1 | Chemiluminescent compounds | GEN-PROBE CARDIFF, LTD. (GB) | 2007-07-19 | — | — | US | claimed |
| EP-1658503-A1 | CHEMILUMINESCENT COMPOUNDS | Molecular Light Technology Research Limited (GB) | 2006-05-24 | — | — | EP | claimed |
| WO-2005022161-A1 | CHEMILUMINESCENT COMPOUNDS | MOLECULAR LIGHT TECHNOLOGY RESEARCH LIMITED (GB) | 2005-03-10 | — | — | WO | claimed |
| WO-2000035865-A2 | TUBULIN-BINDING AGENTS | TULARIK INC. (US) | 2000-06-22 | — | — | WO | claimed |
| US-20240222102-A1 | APOLIPOPROTEIN E ISOTYPE DETECTION BY MASS SPECTROMETRY | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2024-07-04 | — | — | US | disclosed |
| CN-118225957-A | Method for detecting chromogranin A by mass spectrometry | 奎斯特诊断投资有限公司 | 2024-06-21 | — | — | CN | disclosed |
| US-20240168039-A1 | METHODS FOR DETECTING VITAMIN D METABOLITES BY MASS SPECTROMETRY | QUEST DIAGNOSTICS INVEST LLC (US) | 2024-05-23 | — | — | US | disclosed |
| CN-112119310-B | Method for detecting chromogranin A by mass spectrometry | 奎斯特诊断投资有限公司 | 2024-04-09 | — | — | CN | disclosed |
| US-20240110899-A1 | METHODS FOR DETECTING CHROMOGRANIN A BY MASS SPECTROMETRY | QUEST DIAGNOSTICS INVESTMENTS LLC (US) | 2024-04-04 | — | — | US | disclosed |
| CN-117761323-A | Detection of amyloid beta by mass spectrometry | 奎斯特诊断投资有限公司 | 2024-03-26 | — | — | CN | disclosed |
| WO-2001036434-A1 | PREPARATION OF A MACROCYCLIC LACTONE | SYNGENTA PARTICIPATIONS AG (CH) | 2001-05-25 | — | — | WO | disclosed |
| WO-2000035865-A2 | TUBULIN-BINDING AGENTS | TULARIK INC. (US) | 2000-06-22 | — | — | WO | disclosed |
| US-5494815-A | POLYMER CROSSLINKED BY RADIATION OR PEROXIDE TO FORM EPOXIDE GROUPS WHICH REACT WITH SUBSTANCE TO BE IMMOBILIZED; REMAINING EPOXY GROUPS STABILIZED WITH AMINE, CARBOXY OR AMINOACID COMPONENTS | SIEMENS AKTIENGESELLSCHAFT (DE) | 1996-02-27 | — | — | US | disclosed |
| US-5407818-A | Selective detection of enzymes | SIEMENS AKTIENGESELLSCHAFT (DE) | 1995-04-18 | — | — | US | disclosed |
| US-5389533-A | Applying to carrier and crosslinking with high energy radiation or peroxide; stabilization of unreacted epoxy groups | SIEMENS AKTIENGESELLSCHAFT (DE) | 1995-02-14 | — | — | US | disclosed |
| US-5389534-A | Applied to carrier and crosslinked with high energy radiation or peroxide; stabilized unreacted epoxy groups | SIEMENS AKTIENGESELLSCHAFT (DE) | 1995-02-14 | — | — | US | disclosed |
| US-5183749-A | One step fermentation for carrying out hydroxylation or epoxidation or both reactions | SANKYO COMPANY, LTD. (JP) | 1993-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070166759-A1 | Chemiluminescent compounds | CBR3, CBR1, LTC4S | TDP1 2662/4885ATM 2987/4885ALDH1A1 460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.